A new genome-wide study uncovers evidence of the first three-way relationships between human genetic variation, variation in the fungal component of the human microbiome – known as the mycobiome – and risk of developing chronic disease.
Just as a computer’s operating system can be rewritten after a major update, dengue infection can ‘re-programme’ the body’s immune system, leaving a long-lasting genetic imprint that influences how people respond to future infections-an effect not seen with vaccination.
The timing of breakfast in older adults is crucial; later meals are associated with health risks and shorter survival, highlighting the need for proper timing.
For most broken bones, bone cells regrow on their own while patients wear a cast or brace to keep the injury steady.
Black adolescents with mental distress are less likely to use mental health services than their White peers, and Black girls are the least likely to access care, according to new research published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.241733.
A recent study published in Engineering has shed new light on the potential therapeutic effects of berberine (BBR), a natural compound derived from traditional Chinese medicine, in treating diabetic encephalopathy (DE).
Bedfont® Scientific Limited, an innovative med-tech company with over 48 years of knowledge and expertise in the manufacture of medical breath analysis devices, are seeking new strategic distribution partners at this year’s European Respiratory Society (ERS) Congress.
An international team of scientists has revealed how rogue rings of DNA that float outside of our chromosomes – known as extrachromosomal DNA, or ecDNA – can drive the growth of a large proportion of glioblastomas, the most common and aggressive adult brain cancer.
A study reveals that increased walking volume lowers the risk of chronic low back pain, highlighting the importance of daily physical activity for prevention.
NYU Langone Health’s Perlmutter Cancer Center announces the arrival of acclaimed cancer leaders Anirban Maitra, MD, and Manuel Hidalgo, MD, as co-directors of a new Gastrointestinal (GI) Cancer Center.